CN1185961A - Capsule for apoplexy - Google Patents
Capsule for apoplexy Download PDFInfo
- Publication number
- CN1185961A CN1185961A CN96118838A CN96118838A CN1185961A CN 1185961 A CN1185961 A CN 1185961A CN 96118838 A CN96118838 A CN 96118838A CN 96118838 A CN96118838 A CN 96118838A CN 1185961 A CN1185961 A CN 1185961A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- processed
- apoplexy
- hirudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006011 Stroke Diseases 0.000 title claims abstract description 16
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 15
- 239000002775 capsule Substances 0.000 title claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 18
- 241000272074 Bungarus Species 0.000 claims description 10
- 241000237903 Hirudo Species 0.000 claims description 10
- 241000255791 Bombyx Species 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 9
- 239000004863 Frankincense Substances 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 241000489492 Arisaema Species 0.000 claims description 6
- 241000218176 Corydalis Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 210000000941 bile Anatomy 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010048962 Brain oedema Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000006752 brain edema Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 208000014987 limb edema Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000010273 nao xue shuan Substances 0.000 description 1
- 239000009335 naoxintong Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of capsules for preventing and curing apoplexy is prepared from 31 Chinese-medicinal materials such as astragalus root, white atractylodes rhizome, Chinese angelica root, wolfberry fruit, alismatis rhizome, etc. through baking part of raw materials at 50-60 deg. C for 4-6 hrs, grinding others, mixing, 80-mesh sieving and loading into capsules.
Description
The present invention relates to a kind of Chinese medicine Capsule for apoplexy that is used for the treatment of apoplexy.
Apoplexy is a kind of common frdquently encountered disease, and fatality rate is very high, for China's emphasis is captured one of disease.In wind-induced half body not tunnel, facial hemiparalysis, aphasis and because blood supply insufficiency, the brain atrophy that causes, alzheimer disease and the vasculitis etc. that cerebral arteriosclerosis causes are producing very serious harm to human body.Present state internal therapy apoplexy is that the compound Chinese medicinal preparation of cerebrovascular has tens of kinds, " NAOXUESHUAN PIAN " as the production of Lianyun Harbour pharmaceutical factory of traditional Chinese medicine, " HUATUO ZAIZAO WAN " that Qixing Pharmaceutical Factory of Guangzhou produces, " ZHONGFENG HUICHUN WAN " that the Xiu Tang pharmaceutical factory produces respected in Guangzhou, " NAOXINTONG JIAONANG " that Xianyang step-length drugmaker produces etc., the prescription main component of introducing from each tame disclosed description, medication biases toward more selects blood circulation promoting and blood stasis dispelling for use, soothing the channels and quicking the network vessels, suppressing the hyperactive liver and subsiding YANG and so on palliative is main, and the concerted application of drugs in the training unit of effecting a permanent cure is very few, especially on this foundation of acquired constitution of function of spleen and stomach regulating, more do not have and take into account, to such an extent as to often cause after taking medicine that spleen and stomach function is bad, can not continue to take.Also thorough not to the utmost with regard to it selecting on the medicine of taking stopgap measures, as in the disordered brain function treatment, not selecting the Chinese medicine that brain-care is directly arranged for use.The prolonged illness QI and blood is weak more had constipation, paralysed disease limbs that blood stasis is arranged more and suffers from limb swelling is arranged more, and sick just all has the brain swelling that does not wait degree, does not also see the agent of giving suitable diuresis etc., and it all has weak point with medicine composition.Though each tame medicine all has certain curative effect in treatment, in using, clinical practice realizes satisfaction unlike being introduced in its description.
The object of the present invention is to provide a kind of Chinese medicine Capsule for apoplexy that can effectively prevent and treat apoplexy.
The present invention realizes like this, it is according to the pathogenetic etiology and pathogenesis of apoplexy, the traditional Chinese medical science thinks that this disease mostly occurs over 40 years old, because of QI and blood declines few, deficiency of the liver and kindey, dysfunction of the spleen in transportation, visceral dysfunction, yin and yang imbalance and the qi depression to blood stasis that causes, give birth in the phlegm-damp, to such an extent as to the hepatic and renal YIN deficiency, liver-yang is high partially, the sun wind-transformation is moving, the disturbance QI and blood, bleeding resulting from adverse flow of QI holds up phlegm-damp fire upper punch in brain, illiteracy is closed the confused suddenly servant's syncope of key clearly, the horizontal string in meridians blocked then half body tunnel not of sering, apoplexy diseases such as aphasis, and feelings will changes, eating and drinking without temperance, overstrain, climate change mostly is its inducement.Thereby benefiting vital QI and blood has been proposed, nourishing the liver and kidney, invigorating spleen to remove dampness is with Zhi Qiben, blood circulation promoting and blood stasis dispelling, soothing the channels and quicking the network vessels, expelling wind to relieve convulsion, brain-care is to control its target principles of formulating prescriptions, so select the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively to dry 4-6 hour dried disinfecting under 50 ℃-60 ℃ the temperature at interval, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, incapsulate and obtain, the part by weight of its each batching is the Radix Astragali: yellow art: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.
The invention has the advantages that it has given prominence to benefiting vital QI and blood when prescription, nourishing the liver and kidney, invigorating spleen to remove dampness, element culturing fixed folder, the medication that effects a permanent cure of Yin Yang balancing, as the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae etc., also note having enlarged the medication taste that takes stopgap measures simultaneously, as Hirudo, Rhizoma Curcumae Longae, Caulis Spatholobi, Herba Lycopodii, Bungarus Parvus etc., with blood circulation promoting and blood stasis dispelling, the suppressing liver-wind to relieve spasm medicine, painful to reach releasing patient limb, the hardship of limb spasm, be of value to functional rehabilitation, the patient is the long-term bed deficiency of both QI and blood after being ill, constipation is arranged more, added Radix Et Rhizoma Rhei among the we, Semen Persicae rushes down dampness removing heat with loosening bowel to relieve constipation, the blood circulation and promoting silt effect is arranged again, and paralyzed limbs often has edema, and the brain swelling that does not wait degree is just all arranged, so added Rhizoma Alismatis in order to damp and hot, eliminated and suffer from limb edema and brain swelling.Disordered brain function do not wait the existence of degree be stroke patient condition of illness must be arranged, therefore selected Rhizoma Acori Graminei, Radix Polygalae for use with brain-care effect.It is main double its mark of controlling that the present invention has given prominence to the key points to effect a permanent cure, and can effectively prevent and treat apoplexy.According to two First Five-Year Plan of nuclear industry Xianyang hospital from January, 1993---during the nineteen ninety-five December to the 825 routine apoplexy cases of being in hospital with Drug therapy of the present invention, it is evident in efficacy, does not have toxic and side effects, wherein cerebral infarction 559 examples, recovery rate is 47.05%, and total effective rate is 96.24%; Cerebral hemorrhage 266 examples, cure rate are 56.98%, and total effective rate is 92.81%.Simultaneously hemorheology, blood fat, superoxide dismutase (SOD) are detected all than having clear improvement before the treatment.The average hospital days cerebral infarction is 48.9 days, and cerebral hemorrhage is 43.9 days, and these indexs all are better than the requirement in " the sick quality control criterion of planting " (tentative draft) of Ministry of Health of the People's Republic of China in 1992 regulation.
The present invention is described in more detail with embodiment below:
The present invention selects the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, 1 of Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively with oven dry 4-6 hour dried disinfecting in gap under 50 ℃-60 ℃ the temperature, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, every 0.4g packs a capsule into and obtains, and the part by weight of its each batching is the Radix Astragali: the Rhizoma Atractylodis Macrocephalae: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.When taking 3 times on the one, each 5-6 grain, be a course of treatment January.
Claims (1)
- A kind of Chinese medicine Capsule for apoplexy that is used for the treatment of apoplexy, it is characterized in that it selects the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively with oven dry 4-6 hour dried disinfecting in gap under 50 ℃-60 ℃ the temperature, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, incapsulate and obtain, the part by weight of its each batching is the Radix Astragali: the Rhizoma Atractylodis Macrocephalae: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96118838A CN1056296C (en) | 1996-12-26 | 1996-12-26 | Capsule for apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96118838A CN1056296C (en) | 1996-12-26 | 1996-12-26 | Capsule for apoplexy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1185961A true CN1185961A (en) | 1998-07-01 |
| CN1056296C CN1056296C (en) | 2000-09-13 |
Family
ID=5125395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96118838A Expired - Fee Related CN1056296C (en) | 1996-12-26 | 1996-12-26 | Capsule for apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1056296C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098704C (en) * | 1999-12-14 | 2003-01-15 | 王爱国 | Preparation of hemiplegia treating capsule |
| CN1296087C (en) * | 2004-10-15 | 2007-01-24 | 北京国仁堂医药科技发展有限公司 | Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof |
| CN1298338C (en) * | 2005-07-21 | 2007-02-07 | 陈际华 | Cardiovascular and cerebrovascular disease treating medicine |
| CN1319586C (en) * | 2002-12-16 | 2007-06-06 | 闫位国 | Medicinal composition for treating brain apoplexy |
| CN100415262C (en) * | 2006-03-06 | 2008-09-03 | 赵刚 | Medicine for treating cerebral infraction and its preparing method |
| CN102406769A (en) * | 2011-07-11 | 2012-04-11 | 李保明 | Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof |
| CN103463561A (en) * | 2013-08-26 | 2013-12-25 | 荣成市科学技术情报研究所 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
| CN107029106A (en) * | 2017-04-05 | 2017-08-11 | 黄凤玲 | Treat the medicine of apoplexy |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1323683C (en) * | 2005-09-05 | 2007-07-04 | 咸阳步长医药科技发展有限公司 | Medicine composition for treating apoplexy and chest Bi-syndrome and its prepn |
-
1996
- 1996-12-26 CN CN96118838A patent/CN1056296C/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098704C (en) * | 1999-12-14 | 2003-01-15 | 王爱国 | Preparation of hemiplegia treating capsule |
| CN1319586C (en) * | 2002-12-16 | 2007-06-06 | 闫位国 | Medicinal composition for treating brain apoplexy |
| CN1296087C (en) * | 2004-10-15 | 2007-01-24 | 北京国仁堂医药科技发展有限公司 | Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof |
| CN1298338C (en) * | 2005-07-21 | 2007-02-07 | 陈际华 | Cardiovascular and cerebrovascular disease treating medicine |
| CN100415262C (en) * | 2006-03-06 | 2008-09-03 | 赵刚 | Medicine for treating cerebral infraction and its preparing method |
| CN102406769A (en) * | 2011-07-11 | 2012-04-11 | 李保明 | Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof |
| CN102406769B (en) * | 2011-07-11 | 2013-08-14 | 李保明 | Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof |
| CN103463561A (en) * | 2013-08-26 | 2013-12-25 | 荣成市科学技术情报研究所 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
| CN103463561B (en) * | 2013-08-26 | 2015-07-22 | 蒿崑 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
| CN107029106A (en) * | 2017-04-05 | 2017-08-11 | 黄凤玲 | Treat the medicine of apoplexy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1056296C (en) | 2000-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1191740A (en) | Qihe fracture setting plaster with bone retaining liniment | |
| CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
| CN101085223A (en) | Medicine for treating rheumatism and rheumatoid disease | |
| CN101856447B (en) | Capsule capable of clearing heat and purging fire | |
| CN101229355B (en) | Rheumatism soup | |
| CN1056296C (en) | Capsule for apoplexy | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN104338100A (en) | Formula and preparation method of wind-dispelling and bone-strengthening wine | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN102499972B (en) | Pure traditional Chinese medicinal composition for treating endometritis of dairy cow by oral administration and preparation method thereof | |
| CN1114206A (en) | Plaster for curing dysmenorrhea | |
| CN101703710A (en) | Chinese medicinal preparation for treating gout | |
| CN104027750A (en) | Traditional Chinese medicament for treating conjunctivitis | |
| CN102100826A (en) | Chinese medicinal compound preparation for treating canine parvovirus enteritis and preparation method thereof | |
| CN105998583A (en) | Traditional Chinese medicine composition for treating rheumatism of dairy cows and preparation method thereof | |
| CN1062176C (en) | Oral liquid for curing cancer | |
| CN104173929A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN105535779A (en) | Chinese medicinal composition for treating uremia | |
| CN100443114C (en) | Antidiarrheal wiping powder and preparing process thereof | |
| CN104399036A (en) | Medicine composition for treating chronic diarrhea and application of medicine composition | |
| CN1093410C (en) | Preparation method of medicinal liquor for treating rheumatic arthritis | |
| CN103656463A (en) | Traditional Chinese medicine for treating algomenorrhea | |
| CN103720972B (en) | Traditional Chinese herbal medicinal ointment for treating hyperostosis and preparation method thereof | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN110227139A (en) | A kind of Radix Salviae Miltiorrhizae strengthens muscles and bones particle and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |